» Articles » PMID: 33303732

Recurrent Pregnancy Loss

Overview
Specialty General Medicine
Date 2020 Dec 11
PMID 33303732
Citations 200
Authors
Affiliations
Soon will be listed here.
Abstract

Recurrent pregnancy loss is a distressing pregnancy disorder experienced by ~2.5% of women trying to conceive. Recurrent pregnancy loss is defined as the failure of two or more clinically recognized pregnancies before 20-24 weeks of gestation and includes embryonic and fetal losses. The diagnosis of an early pregnancy loss is relatively straightforward, although progress in predicting and preventing recurrent pregnancy loss has been hampered by a lack of standardized definitions, the uncertainties surrounding the pathogenesis and the highly variable clinical presentation. The prognosis for couples with recurrent pregnancy loss is generally good, although the likelihood of a successful pregnancy depends on maternal age and the number of previous losses. Recurrent pregnancy loss can be caused by chromosomal errors, anatomical uterine defects, autoimmune disorders and endometrial dysfunction. Available treatments target the putative risk factors of pregnancy loss, although the effectiveness of many medical interventions is controversial. Regardless of the underlying aetiology, couples require accurate information on their chances of having a baby and appropriate support should be offered to reduce the psychological burden associated with multiple miscarriages. Future research must investigate the pathogenesis of recurrent pregnancy loss and evaluate novel diagnostic tests and treatments in adequately powered clinical trials.

Citing Articles

Exploring Potential Biomarkers in Recurrent Pregnancy Loss: A Literature Review of Omics Studies to Molecular Mechanisms.

Li L, Baek K Int J Mol Sci. 2025; 26(5).

PMID: 40076883 PMC: 11900470. DOI: 10.3390/ijms26052263.


Tacrolimus (FK506) promotes placentation and maternal-fetal tolerance through modulating FASN-CEACAM1 pathway.

Meng X, Shi M, Qian J, Luo Y, Cui L, Li D Front Immunol. 2025; 16:1522346.

PMID: 40046057 PMC: 11879939. DOI: 10.3389/fimmu.2025.1522346.


The Identification of FN1 as an Early Diagnostic Marker for Recurrent Abortion by Single-Exosome Profiling.

Wang C, Lu Z, She G, Chen K, Zhou H, Zhan X Int J Gen Med. 2025; 18:691-702.

PMID: 39963517 PMC: 11830759. DOI: 10.2147/IJGM.S487632.


Potential biomarkers and immune infiltration linking endometriosis with recurrent pregnancy loss based on bioinformatics and machine learning.

Chen J, Li Q, Liu X, Lin F, Jing Y, Yang J Front Mol Biosci. 2025; 12:1529507.

PMID: 39963268 PMC: 11830612. DOI: 10.3389/fmolb.2025.1529507.


PBX1 attenuates inflammation and apoptosis of trophoblast cells induced by LPS through downregulating the transcription of TMUB1: PBX1 ameliorates RSA development.

Zhang X, Wang S, Liang L, Hu F, Zhang X, Cui X J Mol Histol. 2025; 56(2):91.

PMID: 39961876 DOI: 10.1007/s10735-025-10364-z.


References
1.
Fry J . Preparation of mammalian hepatocytes. Methods Enzymol. 1981; 77:130-7. DOI: 10.1016/s0076-6879(81)77017-4. View

2.
Schwartz M, Hayden C, Richardson C, TYSON K, Lobe T . A prospective evaluation of intestinal stenosis following necrotizing enterocolitis. J Pediatr Surg. 1982; 17(6):764-70. DOI: 10.1016/s0022-3468(82)80443-0. View

3.
Nybo Andersen A, Wohlfahrt J, Christens P, Olsen J, Melbye M . Maternal age and fetal loss: population based register linkage study. BMJ. 2000; 320(7251):1708-12. PMC: 27416. DOI: 10.1136/bmj.320.7251.1708. View

4.
Almeida N, Basso O, Abrahamowicz M, Gagnon R, Tamblyn R . Risk of Miscarriage in Women Receiving Antidepressants in Early Pregnancy, Correcting for Induced Abortions. Epidemiology. 2016; 27(4):538-46. DOI: 10.1097/EDE.0000000000000484. View

5.
Avalos L, Galindo C, Li D . A systematic review to calculate background miscarriage rates using life table analysis. Birth Defects Res A Clin Mol Teratol. 2012; 94(6):417-23. DOI: 10.1002/bdra.23014. View